“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z
6 days ago · TechCrunch
Global
& newspaper;
Read Full Article →
Sourced From
TechCrunch
Vijay Pande — who left a16z's roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a "discovery" science to an "engineering" one, why clinical trials are still brut…
Source: TechCrunch — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: TechCrunch — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.